SAN DIEGO, July 16 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for
the second quarter of 2007 on Monday, July 23, 2007 at 5:00 p.m. ET/2:00
p.m. PT. Daniel M. Bradbury, Amylin's President and Chief Executive
Officer, will lead the call. On the same date post market, Amylin will
release financial results for the second quarter of 2007.
The call will be webcast live through Amylin's corporate website and a
recording will be made available following the close of the call. To access
the webcast, please log on to http://www.amylin.com approximately fifteen
minutes prior to the call to register, download and install any necessary
audio software. For those without access to the Internet, the live call may
be accessed by phone by calling (800) 561-2693 (domestic) or (617) 614-3523
(international), passcode 23581339. A replay of the call will also be
available by phone for 24 hours beginning approximately one hour after the
close of the call and can be accessed at (888) 286-8010 (domestic) or (617)
801-6888 (international), passcode 98270256.
About Amylin
Amylin Pharmaceuticals is a biopharmaceutical company committed to
improving lives through the discovery, development and commercialization of
innovative medicines. Amylin has developed and gained approval for two
first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate)
injection and BYETTA(R) (exenatide) injection. Amylin's research and
development activities leverage the company's expertise in metabolism to
develop potential therapies to treat diabetes and obesity. Amylin is
located in San Diego, California with over 1,700 employees nationwide.
Further information on Amylin Pharmaceuticals and its pipeline in
metabolism is available at http://www.amylin.com.
SOURCE Amylin Pharmaceuticals, Inc.
 back to top
Related links:
http://www.amylin.com
CONTACT:
Alice Bahner Izzo, Executive Director,
Corporate Affairs of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272
|
